Provided by Tiger Trade Technology Pte. Ltd.

WUXI BIO

34.740
-0.780-2.20%
Volume:5.72M
Turnover:198.76M
Market Cap:143.75B
PE:44.27
High:35.520
Open:35.520
Low:34.300
Close:35.520
52wk High:44.000
52wk Low:16.200
Shares:4.14B
HK Float Shares:4.14B
Volume Ratio:1.22
T/O Rate:0.14%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.785
ROE:10.50%
ROA:5.89%
PB:2.81
PE(LYR):44.27
PS:6.31

Loading ...

Hong Kong Stocks Surge: CRO Concept Stocks Rally in Afternoon Session with WUXI BIO (02269) Up Over 7%; Analysts Highlight Industry Consolidation Trend

Stock News
·
Dec 04, 2025

HK Movers | Biotech Stocks Rise. Ascletis up 9%; Antengene up over 5%; Remegen, Laekna, Akeso, Hua Medicine up About 4%

Tiger Newspress
·
Dec 04, 2025

HK Movers | Biotech Stocks Fall. Ascletis-B down 11%; Hua Medicine-B, Mabpharm-B down about 7%; Antengene-B down 5%; Ascentage-B down 4%.

Tiger Newspress
·
Dec 03, 2025

WuXi Biologics Extends Global Crdmo Network to Qatar Through Strategic Mou Signed With Qatar Free Zones Authority

THOMSON REUTERS
·
Dec 02, 2025

Wuxi Biologics (Cayman) Stock Sheds 1.1% in Hong Kong

Dow Jones
·
Dec 02, 2025

WuXi Biologics Announces First Integrated CRDMO Center in Middle East

Reuters
·
Dec 02, 2025

Wuxi Biologics (Cayman) Stock Climbs 1.8% in Hong Kong

Dow Jones
·
Dec 01, 2025

Wuxi XDC Cayman Inc. Files HKEX Disclosure on 3,000 New Shares Issued at HKD 7.501 Each

Reuters
·
Dec 01, 2025

WUXI BIO (02269) Issues 10.369 Million Shares Under Share Scheme

Stock News
·
Nov 28, 2025

WuXi Biologics (02269) Announces Share Capital Increase Through Option Exercises

Bulletin Express
·
Nov 28, 2025

Analysis of Southbound Stock Connect Holdings as of November 28

Stock News
·
Nov 28, 2025

Those who invested in WuXi Biologics (Cayman) (HKG:2269) a year ago are up 114%

Simply Wall St.
·
Nov 28, 2025

Wuxi Biologics (Cayman) Stock Falls 2.0% in Hong Kong

Dow Jones
·
Nov 27, 2025

WUXI BIO (02269) Issues 4.01 Million Shares Due to Option Exercise

Stock News
·
Nov 26, 2025

HK Pharma Shares Gained. CSPC Pharma Up 7%; 3SBio Up 6%; Remegen Up 4%; Sino Biopharm, Junshi Bio And Hengrui Pharma Up 3%

Tiger Newspress
·
Nov 26, 2025

WUXI BIO (02269) Issues 6.05 Million Shares Due to Option Exercise

Stock News
·
Nov 25, 2025

Wuxi Biologics (Cayman) Stock Advances 4.1% in Hong Kong

Dow Jones
·
Nov 24, 2025

HK Stocks Movement | CRO Sector Rebounds as Industry Performance Expected to Recover in H2; Morgan Stanley Sees Attractive Valuations in WuXi Group

Stock News
·
Nov 24, 2025

HK Movers|Biotech Shares Gained. 3SBio And Hengrui Pharma Up 5%; Tigermed Up 3%; SKB Bio, JW Therap, Remegen And Wuxi XDC Up 2%

Tiger Newspress
·
Nov 24, 2025

Hong Kong Stock Concept Tracking | Strong Performance Growth in Innovative Drug Sector, Upstream CXO Industry Adjustments Largely Completed (With Concept Stocks)

Stock News
·
Nov 24, 2025